STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy.
Ontology highlight
SUBMITTER: Gerthofer V
PROVIDER: S-EPMC8462007 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA